Skip to content
Search

Latest Stories

Patients experience lower mortality rates when treated by female doctors, study reveals

Patients experience lower mortality rates when treated by female doctors, study reveals

Women are more likely to benefit from receiving treatment from female doctors than men

If you believe you'll feel better under the care of a female doctor, you may not be wrong. Researcher have found a correlation between the gender of physicians and clinical outcomes for patients.


Hospital patients have lower mortality and readmission rates when treated by female physicians, according to a study published recently in the journal Annals of Internal Medicine.

Moreover, the benefit of receiving care from female physicians was found to be larger for female patients than for male patients.

Female patients showed a mortality rate of 8.15 per cent when treated by a female doctor, compared to 8.38 per cent under the care of a male physician.

Among men, 10.15 per cent experienced mortality within 30 days of discharge under the care of a female doctor, compared to 10.23 percent with a male physician.

It is a small but “significant” difference, noted the scientists from the University of California, Los Angeles (UCLA) who suggested that the difference could be due to male doctors underestimating the severity of their female patients’ illnesses.

They also proposed that the effect could be due to female doctors communicating with their female patients better, and women finding it more comfortable engaging in detailed and sensitive conversations with doctors of the same gender, potentially resulting in better diagnoses and treatment.

Dr Yusuke Tsugawa, the senior author of the study and an associate professor at the David Geffen School of Medicine at UCLA, noted that their research indicated disparities in medical practice between female and male physicians, with a significant impact on patients' health outcomes.

For the study, the researchers used data of Medicare fee-for-service beneficiaries hospitalized with medical conditions between 2016 and 2019 in the United States.

Of 458,100 female and 319,800 male patients included in the study, approximately 31 percent of them were treated by female physicians.

The study found that female patients had a lower likelihood of being readmitted within 30 days if they were under the care of a female doctor. Specifically, 15.23 percent of women with a female physician were readmitted, compared with 16.71 percent of women with a male physician.

Dr Tsugawa emphasised the importance of conducting additional research into the underlying mechanisms linking physician gender with patient outcomes, as well as understanding why the benefits differed between female and male patients.

This exploration has “the potential to improve patient outcomes across the board,” he said.

Acknowledging that female physicians deliver high-quality care and that increasing their representation benefits patients, the researchers recommended addressing pay disparities within the profession.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less